• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCICENCS IMPLANTS SA OSV II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCICENCS IMPLANTS SA OSV II Back to Search Results
Catalog Number 909708S
Device Problem Obstruction of Flow (2423)
Patient Problem Injury (2348)
Event Date 12/14/2020
Event Type  Injury  
Manufacturer Narrative
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
 
Event Description
A facility reported that after implantation, the ventricular catheter of the osv ii (product id 909708s) was blocked, over-drainage occurred and it was slit, making it necessary to replace it.There was increased surgery time, but the amount of time is unknown.
 
Manufacturer Narrative
An evaluation of the actual osv ii valve could not be performed because the device was discarded at the facility.However, lot number was provided ; therefore, device history records were reviewed which revealed no anomalies that could explain the reported event.Failure analysis: the surgeon expressed concerns with the osv ii that he knows from a long time and is wondering whether the valve operating characteristics have changed: he feels that the ruby part may remain wedged with the membrane (diaphragm).A review of the manufacturing process since 2016 revealed no material change, no design change, no process change, no components supplier / design change : ruby pin and seat and the silicone elastomer diaphragm are unchanged: valve operating characteristics have not changed.Root cause - without actual device to analyze, complaints are unverifiable and exact root cause could not be determined.Overdrainage is a known, patient-related complication of valve therapy, as stated in the product instructions for use.Hydrocephalus shunt systems obstruction is known to be correlated to overdrainage: overdrainage leads to slit ventricle, blocking the ventricular catheter: then residues (from plexus choroid) can move along the shunt and block the valve mechanism.No further investigation nor corrective action is deemed required.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSV II
Type of Device
OSV II
Manufacturer (Section D)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
2905 route des dolines
sophia antipolis F-069 21
FR  F-06921
MDR Report Key11396554
MDR Text Key234219085
Report Number9612007-2021-00016
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K971799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/13/2020
Device Catalogue Number909708S
Device Lot Number0201173
Was Device Available for Evaluation? No
Date Manufacturer Received04/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-